Dose Escalation of an Evans Blue Modified Radiolabeled Somatostatin Analogue (177)Lu-DOTA-EB-TATE in the Treatment of Metastatic Neuroendocrine Tumors

PURPOSE: To evaluate the safety and efficacy of (177)Lu-DOTA-EB-TATE, a radiolabeled somatostatin analogue modified by Evans Blue, at escalating doses, to increase tumor retention in patients with progressive metastatic neuroendocrine tumors (NETs). METHODS: Thirty-three patients with metastatic NET...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Eur J Nucl Med Mol Imaging
Main Authors: Liu, Qingxing, Cheng, Yuejuan, Zang, Jie, Sui, Huimin, Wang, Hao, Jacobson, Orit, Zhu, Zhaohui, Chen, Xiaoyuan
Format: Artigo
Sprog:Inglês
Udgivet: 2019
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7080608/
https://ncbi.nlm.nih.gov/pubmed/31832728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-019-04530-1
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker